SAVE THE DATE
Wednesday, April 24, 2013
7:00 am – 3:30 pm
Center for Biotechnology and Interdisciplinary Studies (CBIS) Auditorium, Rensselaer Polytechnic Institute, Troy, NY
Please mark your calendar for April 24, 2013, as the NY CAP Research Alliance brings together researchers, policymakers and stakeholders to welcome two internationally recognized researchers and shares its progress toward building a new cooperative translational medicine research model in New York State’s Capital Region.
The Symposium is sponsored by Albany Medical Center, Rensselaer Polytechnic Institute and the University at Albany, the three founding institutions of the NY CAP Research Alliance, established in 2011 as part of Governor Andrew Cuomo’s regional economic development initiative. The Alliance funds biomedical research projects that have potential for commercialization and involve collaboration among scientists from at least two of the three founding institutions.
- Andrew D. Ellington, PhD, Professor of Chemistry/Biochemistry, the University at Texas at Austin, where the Ellington Lab’s research focuses on developing novel synthetic organisms based on altering the translational apparatus and developing modular nucleic acid software. The translational engineering centers on the introduction of novel amino acids into proteins.
- Donald L. Price, MD, Professor of Pathology, Neurology and Neuroscience, The Johns Hopkins University School of Medicine, and Director Emeritus of its Alzheimer’s Disease Research Center, whose research focuses on the study of neurodegenerative diseases and the investigation of experimental therapeutic strategies that prepare the way for translation of basic science discoveries to treatments of humans with neurological illnesses.
- Researchers from Albany Medical Center, Rensselaer Polytechnic Institute and the University at Albany who were recently awarded grants through the Alliance.